These Analysts Slash Their Forecasts On GeneDx After Q4 Results

GeneDx Holdings Corp (NASDAQ:WGS) reported better-than-expected fourth-quarter financial results on Monday.GeneDx reported quarterly earnings of 14 cents per share which beat the analyst consensus estimate of 11 cents per share. The company reported quarterly sales of $120.989 million which beat the analyst consensus estimate of $120.407 million.GeneDx Holdings affirmed FY2026 sales guidance of $540.000 million to $555.000 million.GeneDx shares fell 6.1% to trade at $81.82 on Tuesday.These analysts made cha ...